Those assays are super helpful, but don't replicate what happens in humans. They are good boxes to check, and can help weed out compounds early, but just because a compound passes the assay doesn't guarantee something weird won't pop up in humans.
The cell line assays replicate much of what happens in humans, but not all of it, in particular the interactions between different tissues. For example, a drug might be toxic in a liver assay because a reactive metabolite damages the cells. But in an actual human, you might never see those high of concentrations in the liver or there may be a process (like glutathione adducts) that deactivates the metabolite and prevents cell damage.
it’s not a perfect model, but i think it’s a better proxy than a mouse.
You can throw away animal models for tox screens forever, and that's great news. It will save vast amount of time and money. By using a much better proxy model for humans (slices aren't organs, they have different rheological characteristics and morphology, but they're a damn sight better than mice), you'll wash out candidates earlier and faster, and hopefully enrich the pipeline.
Slowly but surely, and it's good to see steps in this direction.